Avacta Group - Termination of coverage
Edison Investment Research is terminating coverage on Avacta Group (AVCT), BCI Minerals (BCI), Destiny Pharma (DEST), Globalworth Real Estate...
264 Views
Avacta Group - New JV gives further validation to Affimers
Avacta has announced a joint venture with Daewoong Pharmaceuticals to develop mesenchymal stem cell (MSC) therapies incorporating Affimers. The...
1k Views
Avacta Group - Executive interview
In this video, Alastair Smith, CEO of Avacta Group, discusses the progress the company has made this year. This includes new and expanded...
1.7k Views
Avacta Group - ADC, partnerships as easy as one, two, three
Avacta’s 12-month results to July 2019 highlight ongoing momentum, as evidenced by three new partnerships (LG Chem, ADC Therapeutics and New...
1.1k Views
Avacta Group - Affimer drug conjugates attracting interest
Avacta has announced a collaboration and licensing agreement with ADC Therapeutics to develop multiple Affimer drug conjugates. The conjugates will...
1.3k Views